CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.

导出 LinkOut

翻译打印收藏纠错

第一作者： Eameema,Muntimadugu

第一单位： Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad 500037, India.

作者： Eameema,Muntimadugu ^[1] ; Rajendra,Kumar ^[2] ; Shantikumar,Saladi ^[3] ; Towseef Amin,Rafeeqi ^[4] ; Wahid,Khan ^[5]

作者单位： Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad 500037, India. ^[1] UGC Centre of Excellence in Applications of Nanomaterials, Nanoparticles, and Nanocomposites, Panjab University, Chandigarh 160014, India. ^[2] Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Hyderabad 500037, India. ^[3] Biochemistry, Cellular and Molecular Biology Laboratories, Central Research Institute of Unani Medicine (CRIUM), Hyderabad 500038, India. ^[4] Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad 500037, India. Electronic address: wahid.niperhyd@gov.in. ^[5]

关键词 CD44 receptors Cancer stem cells Combinational chemotherapy Hyaluronic acid Paclitaxel Polymeric nanoparticles Salinomycin